Syros Pharmaceuticals, Inc. (SYRS)

NASDAQ: SYRS · IEX Real-Time Price · USD

5.11

-0.45 (-8.09%)

At close: Apr 17, 2024, 4:00 PM

4.730

-0.380 (-7.44%)

After-hours: Apr 17, 2024, 7:59 PM EDT

Syros Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	141.65	170.55	95.39	177.07	41.73	50.52	32.4	59.07	36.39	60.46
Short-Term Investments	0	34.84	38.07	0	49.98	49.79	39.84	25.01	0	0
Cash & Cash Equivalents	141.65	205.39	133.46	177.07	91.71	100.32	72.24	84.08	36.39	60.46
Cash Growth	-31.04%	53.90%	-24.63%	93.08%	-8.58%	38.86%	-14.08%	131.03%	-39.81%	-
Receivables	0	1.69	0	0.01	20	0	0	0.87	0	0
Other Current Assets	3.34	4.31	3.13	1.48	2.81	1.42	0.92	0.57	0.06	0.08
Total Current Assets	144.98	211.39	136.59	178.56	114.51	101.73	73.16	85.51	36.45	60.54
Property, Plant & Equipment	19.48	24.66	27.29	29.64	31.89	3.86	3.94	4.85	4.8	0.88
Long-Term Investments	0	0	13.04	0	3.09	0.29	0.29	0	0	0
Other Long-Term Assets	3.71	8.43	6.03	5.05	0.49	0.88	1.1	0.97	2.38	0.07
Total Long-Term Assets	23.19	33.09	46.35	34.69	35.47	5.03	5.33	5.82	7.18	0.95
Total Assets	168.17	244.49	182.94	213.25	149.98	106.77	78.49	91.32	43.63	61.49
Accounts Payable	11.54	6.41	3.69	3.6	5.85	3.31	2.28	2.42	5.04	0.93
Deferred Revenue	0	4.33	10.18	22.09	28.38	10.2	0	0.55	0	0
Current Debt	8.99	2.07	2.01	1.73	1.28	0.01	0.05	0.17	0.13	0
Other Current Liabilities	16.15	17.97	15.62	1.21	-11.99	6.01	10.08	6.43	2.79	0.32
Total Current Liabilities	36.68	30.78	31.51	28.62	23.52	19.53	12.41	9.57	7.96	1.25
Long-Term Debt	53.08	61.5	63.18	64.49	24.64	0.02	0.01	0.05	0.21	0
Other Long-Term Liabilities	61.75	24.47	3.03	29.59	22.64	8.63	0.75	1.1	83.43	82.01
Total Long-Term Liabilities	114.83	85.97	66.21	94.07	47.28	8.65	0.75	1.15	83.64	82.01
Total Liabilities	151.51	116.75	97.72	122.7	70.79	28.18	13.16	10.72	91.6	83.27
Total Debt	62.08	63.57	65.19	66.21	25.92	0.03	0.05	0.22	0.34	0
Debt Growth	-2.35%	-2.49%	-1.54%	155.48%	83503.23%	-41.51%	-76.02%	-34.81%	-	-
Retained Earnings	-722.81	-558.23	-463.58	-377.02	-292.98	-217.55	-155.27	-101.26	-53.51	-23.7
Comprehensive Income	0	0.1	-0.08	0	0.02	-0	-0.04	-0.01	0	0
Shareholders' Equity	16.66	127.74	85.22	90.55	79.18	78.59	65.32	80.6	-47.96	-21.77
Net Cash / Debt	79.57	141.82	68.26	110.86	65.79	100.29	72.19	83.86	36.05	60.46
Net Cash / Debt Growth	-43.89%	107.75%	-38.42%	68.50%	-34.40%	38.92%	-13.91%	132.59%	-40.37%	-
Net Cash Per Share	2.81	11.23	10.92	24.07	16.36	30.71	28.41	66.05	182.06	396.47
Working Capital	108.3	180.61	105.08	149.93	91	82.21	60.75	75.94	28.49	59.29
Book Value Per Share	0.59	10.11	13.63	19.66	19.69	24.07	25.71	63.48	-242.21	-142.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).